Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Annu Rev Microbiol. 2010;64:293-311. doi: 10.1146/annurev.micro.112408.134043.
Mycobacterium tuberculosis, which causes tuberculosis, remains a major human public health threat. This is largely due to a sizeable reservoir of latently infected individuals, who may relapse into active disease decades after first acquiring the infection. Furthermore, patients have a very slow response to treatment of active disease. Latency and antibiotic tolerance are commonly taken as a proxy for dormancy, a stable nonreplicative state. However, latency is a clinical term that is solely defined by a lack of disease indicators. The actual state of the bacterium in human latency is not well understood. Here we evaluate the results of several in vitro models of dormancy and consider the applicability of various animal models for studying aspects of human latency and resistance to killing by antibiotics. Furthermore, we propose a model for the initiation of dormancy and resuscitation during infection.
结核分枝杆菌(Mycobacterium tuberculosis)可引起结核病,仍然是人类公共卫生的主要威胁。这主要是由于大量潜伏性感染个体的存在,这些个体可能在首次感染后数十年内复发为活动性疾病。此外,患者对活动性疾病的治疗反应非常缓慢。潜伏期和抗生素耐药性通常被视为休眠的替代指标,即一种稳定的非复制状态。然而,潜伏期是一个临床术语,仅通过缺乏疾病指标来定义。人类潜伏期中细菌的实际状态尚不清楚。在这里,我们评估了几种休眠体外模型的结果,并考虑了各种动物模型在研究人类潜伏和对抗生素杀伤的抗性方面的适用性。此外,我们提出了一种感染期间休眠和复苏的起始模型。